UK Exports

Fast lanes to growth

  • Share

The study shows automotive, engineering, oil and gas and pharmaceuticals at the core of UK goods export growth over the next five years. But sector-specific strategies are needed across all industries where there is a significant opportunity to meet the demands of some of the world’s fastest growing economies.


Automotive driving growth in China and South East Asia

  • UK automotive exports to China are expected to grow 11.6% - outpacing overall market growth (9.9%) – making it the UK’s top automotive trading partner by 2017
  • UK exports of personal vehicles to Thailand are expected to rise from $302 million in 2012, to $617 million by 2017, with the UK capturing a 53% share of the entire import market
  • UK exporters could emulate this success across the South East Asia by increasing their existing share in rapidly growing automotive markets, particularly Malaysia and Indonesia

Engineering success in the Middle East

  • The Middle East presents a key opportunity for UK engineering, with firms claiming an increasing share of UAE imports, rising from 7% in 2012 to 8.1% in 2017 at a value of $2.5 billion
  • The UK’s high-tech success is expected to continue over the next five years, with growth in turbo jet exports to Qatar alone forecast to grow from $273 million in 2012 to $481 million in 2017

Oil and gas firms head to Latin America

  • UK exports of crude oil and petroleum to Chile are forecast to rise from $397 million in 2012 to $771 million in 2017
  • While non-crude oil exports to Brazil are set to swell from $123 million in 2012 to $198 million five years later
  • Non-crude UK exports are rising to both Colombia (18.2%) and Chile (16.2%) with a combined forecast value of $62.6 million by 2017

Biopharma opportunities in China and Latin America

  • The UK pharma sector, whilst historically strong, is losing makret share with Western trade routes, as out-of-patent drug manufacturing booms in Asia
  • UK biopharma exports to China are expected to double from $52 million in 2012 to $104 million by 2017, with Chinese biopharma imports set to rise to $2.5 billion by 2017 (from $1.4 billion in 2012).
  • Latin America is another key area for biopharma, with rapid growth in Argentina (from $568 million in 2012 to $925 million in 2017) and Venezuela (from $432 million in 2012 to $760 million in 2017)